VOR Biopharma Inc. - Ownership Filing by Frazier Life Sciences Entities

Frazier Life Sciences Public Fund, L.P. and its related entities (collectively, "Reporting Persons") have reported beneficial ownership of 5.8% of VOR Biopharma Inc.'s common stock, totaling 2,258,001 shares. This filing, dated December 19, 2025, indicates a change in ownership as of December 18, 2025. The Reporting Persons, including Frazier Life Sciences XI, L.P. and Frazier Life Sciences XII, L.P., collectively hold a significant stake in the company. The filing specifies that no members of the investment committees for the general partners are attributed beneficial ownership of the securities. The Reporting Persons certify that the securities were not acquired or held for the purpose of influencing the control of the issuer.